Published in Infect Immun on June 01, 1999
Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut (2004) 5.32
Dysbiosis in inflammatory bowel disease. Gut (2004) 5.01
Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol (2013) 4.34
Commensal Bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host Microbe (2011) 3.46
Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut (2012) 3.09
Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet (2010) 2.51
Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev (2002) 2.29
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. Gut (2006) 2.24
Serum immune responses predict rapid disease progression among children with Crohn's disease: immune responses predict disease progression. Am J Gastroenterol (2006) 2.14
Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut (2003) 2.02
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94
Bacterial sensor Nod2 prevents inflammation of the small intestine by restricting the expansion of the commensal Bacteroides vulgatus. Immunity (2014) 1.94
Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota. BMC Gastroenterol (2010) 1.41
Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun (2000) 1.33
Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol (2007) 1.32
Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut (2006) 1.20
Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria. Clin Diagn Lab Immunol (2003) 1.14
HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats. PLoS One (2014) 1.07
Gnotobiotic IL-10; NF-kappaB mice develop rapid and severe colitis following Campylobacter jejuni infection. PLoS One (2009) 1.02
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies. World J Gastroenterol (2009) 0.98
Toxoplasma gondii rhoptry 16 kinase promotes host resistance to oral infection and intestinal inflammation only in the context of the dense granule protein GRA15. Infect Immun (2013) 0.98
Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunology (2004) 0.98
Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol (2004) 0.96
The colitis-associated transcriptional profile of commensal Bacteroides thetaiotaomicron enhances adaptive immune responses to a bacterial antigen. PLoS One (2012) 0.93
High proportions of proinflammatory bacteria on the colonic mucosa in a young patient with ulcerative colitis as revealed by cloning and sequencing of 16S rRNA genes. Dig Dis Sci (2007) 0.93
Characterization of adherent bacteroidales from intestinal biopsies of children and young adults with inflammatory bowel disease. PLoS One (2013) 0.93
An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infect Immun (2004) 0.92
Animal models of inflammatory bowel disease: a review. Inflammopharmacology (2014) 0.92
Impact of the gut microbiota on rodent models of human disease. World J Gastroenterol (2014) 0.92
Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front Microbiol (2014) 0.91
Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice. Inflamm Bowel Dis (2009) 0.90
The intestinal microbiome in spondyloarthritis. Curr Opin Rheumatol (2015) 0.90
Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin Cancer Biol (2013) 0.90
Pathogenic role of the gut microbiota in gastrointestinal diseases. Intest Res (2016) 0.88
Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats. Clin Diagn Lab Immunol (2004) 0.87
Draft genome sequence of Bacteroides vulgatus PC510, a strain isolated from human feces. J Bacteriol (2011) 0.86
Dysregulated luminal bacterial antigen-specific T-cell responses and antigen-presenting cell function in HLA-B27 transgenic rats with chronic colitis. Immunology (2005) 0.85
Microbial sensing by the intestinal epithelium in the pathogenesis of inflammatory bowel disease. Int J Inflam (2010) 0.85
HLA-B27 misfolding and spondyloarthropathies. Prion (2009) 0.84
The Mammalian Microbiome and Its Importance in Laboratory Animal Research. ILAR J (2015) 0.81
Mechanisms of Microbe-Host Interaction in Crohn's Disease: Dysbiosis vs. Pathobiont Selection. Front Immunol (2015) 0.80
Immunogenetic phenotypes in inflammatory bowel disease. World J Gastroenterol (2006) 0.80
Lipopolysaccharide induces CD25-positive, IL-10-producing lymphocytes without secretion of proinflammatory cytokines in the human colon: low MD-2 mRNA expression in colonic macrophages. J Clin Immunol (2004) 0.80
Adoptive transfer of nontransgenic mesenteric lymph node cells induces colitis in athymic HLA-B27 transgenic nude rats. Clin Exp Immunol (2006) 0.79
Microbial and histopathologic considerations in the use of mouse models of inflammatory bowel diseases. Inflamm Bowel Dis (2012) 0.77
Impaired humoral immune response against mycobacterial 65-kDa heat shock protein (HSP65) in patients with inflammatory bowel disease. Dig Dis Sci (2002) 0.76
A Possible Role of Intestinal Microbiota in the Pathogenesis of Ankylosing Spondylitis. Int J Mol Sci (2016) 0.76
Disease Severity and Immune Activity Relate to Distinct Interkingdom Gut Microbiome States in Ethnically Distinct Ulcerative Colitis Patients. MBio (2016) 0.75
Colonic Lesions, Cytokine Profiles, and Gut Microbiota in Plasminogen-Deficient Mice. Comp Med (2015) 0.75
Treatment with a Monoclonal Anti-IL-12p40 Antibody Induces Substantial Gut Microbiota Changes in an Experimental Colitis Model. Gastroenterol Res Pract (2016) 0.75
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats. J Exp Med (1994) 5.46
Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: an animal model of HLA-B27-associated human disorders. Cell (1990) 4.84
Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest (1996) 4.59
Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients. J Immunol (1997) 3.05
CD4+ T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: increased T helper cell type 1 response and ability to transfer disease. J Exp Med (1998) 3.01
T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76
Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect Immun (1981) 2.34
Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut (1991) 2.24
Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation (1993) 2.03
Arthropathic properties of cell wall polymers from normal flora bacteria. Infect Immun (1986) 1.88
The obligate anaerobic faecal flora of patients with Crohn's disease and their first-degree relatives. Scand J Gastroenterol (1988) 1.83
Assessment of leukocyte involvement during ischemia and reperfusion of intestine. Methods Enzymol (1990) 1.82
Bacteriological studies of experimental ulcerative colitis. Am J Clin Nutr (1979) 1.75
Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology (1991) 1.72
Spontaneously colitic C3H/HeJBir mice demonstrate selective antibody reactivity to antigens of the enteric bacterial flora. J Immunol (1997) 1.69
The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol (1998) 1.63
Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology (1996) 1.63
Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology (1990) 1.59
Role of appendix in the development of inflammatory bowel disease in TCR-alpha mutant mice. J Exp Med (1996) 1.59
Lymphoid hyperplasia, autoimmunity, and compromised intestinal intraepithelial lymphocyte development in colitis-free gnotobiotic IL-2-deficient mice. J Immunol (1998) 1.57
Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats. J Rheumatol (1989) 1.53
Relation between concentrations of metronidazole and Bacteroides spp in faeces of patients with Crohn's disease and healthy individuals. J Clin Pathol (1981) 1.49
Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology (1999) 1.47
Hepatic effects of jejunoileal bypass for morbid obesity. Am J Surg (1974) 1.47
Transfer of the inflammatory disease of HLA-B27 transgenic rats by bone marrow engraftment. J Exp Med (1993) 1.44
Selected bacterial antibodies in Crohn's disease and ulcerative colitis. Scand J Gastroenterol (1983) 1.37
T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B27 transgenic rats. J Immunol (1996) 1.28
Stimulation of transforming growth factor beta1 by enteric bacteria in the pathogenesis of rat intestinal fibrosis. Gastroenterology (1998) 1.20
Correlation of cecal microflora of HLA-B27 transgenic rats with inflammatory bowel disease. Infect Immun (1998) 1.05
Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, bacteria, and bacterial polymers. Infect Immun (1995) 1.04
Hepatic steatosis after intestinal bypass--prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition. Gastroenterology (1982) 0.99
Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol (1991) 8.36
Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun (1998) 7.86
Experimental models of inflammatory bowel disease. Gastroenterology (1995) 6.28
Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol (1991) 6.00
Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. J Clin Invest (1996) 4.59
Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol (1982) 4.35
Genetic variability of Bacillus anthracis and related species. J Clin Microbiol (1995) 4.26
Identification of a region of genetic variability among Bacillus anthracis strains and related species. J Bacteriol (1996) 3.92
Sequence-based differentiation of strains in the Mycobacterium avium complex. J Bacteriol (1993) 3.63
Characterization of the variable-number tandem repeats in vrrA from different Bacillus anthracis isolates. Appl Environ Microbiol (1997) 3.36
Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology (1992) 3.04
Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease). J Clin Microbiol (1997) 3.01
Extensive DNA sequence conservation throughout the Mycobacterium tuberculosis complex. J Clin Microbiol (1994) 2.89
Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem (1999) 2.79
Molecular phylogeny of the Mycobacterium avium complex demonstrates clinically meaningful divisions. J Infect Dis (1994) 2.69
Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol (1999) 2.55
Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J Clin Invest (2000) 2.27
Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients. J Clin Microbiol (1995) 2.24
The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol (2000) 2.21
Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor. Hepatology (1998) 2.18
Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii. Int J Syst Bacteriol (1996) 2.18
Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol (1983) 2.15
Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation (1993) 2.03
Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut (2003) 2.02
Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun (2001) 1.94
IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol (1999) 1.83
Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol (1997) 1.80
Enhanced survival and mucosal repair after dextran sodium sulfate-induced colitis in transgenic mice that overexpress growth hormone. Gastroenterology (2001) 1.77
Studies on the epidemiology of antibiotic-associated Clostridium difficile colitis. Am J Clin Nutr (1980) 1.73
Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline. Gastroenterology (1991) 1.72
Rapid 16S ribosomal DNA sequencing from a single colony without DNA extraction or purification. Biotechniques (1991) 1.70
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
Suppression of Clostridium difficile by normal hamster cecal flora and prevention of antibiotic-associated cecitis. Infect Immun (1981) 1.66
Leptotrichia sanguinegens sp. nov., a new agent of postpartum and neonatal bacteremia. Clin Infect Dis (1995) 1.62
Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology (1990) 1.59
Interaction of Clostridium difficile and Escherichia coli with microfloras in continuous-flow cultures and gnotobiotic mice. Infect Immun (1986) 1.58
Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology (1985) 1.57
Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic Campylobacter gracilis-like clinical isolates. Int J Syst Bacteriol (1996) 1.55
Mucosal injury and inflammation in a model of chronic granulomatous colitis in rats. Gastroenterology (1993) 1.54
Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells. J Immunol (1998) 1.51
Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med (2008) 1.48
Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats. Gastroenterology (1999) 1.47
Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile. J Infect Dis (1983) 1.45
Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats. Gastroenterology (1994) 1.45
Population dynamics of ingested Clostridium difficile in the gastrointestinal tract of the Syrian hamster. J Infect Dis (1985) 1.44
Continuous stimulation by normal luminal bacteria is essential for the development and perpetuation of colitis in Tg(epsilon26) mice. Gastroenterology (2001) 1.43
Emergence of nosocomial methicillin-resistant Staphylococcus aureus and therapy of colonized personnel during a hospital-wide outbreak. Infect Control (1987) 1.36
Evaluation of eight cephalosporins in hamster colitis model. Antimicrob Agents Chemother (1981) 1.35
Gnotobiotic models for study of the microbial ecology of Clostridium difficile and Escherichia coli. J Infect Dis (1986) 1.34
Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect Immun (2000) 1.33
Cloning and pharmacological characterization of human alpha-1 adrenergic receptors: sequence corrections and direct comparison with other species homologues. J Pharmacol Exp Ther (1995) 1.33
Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut (1996) 1.31
Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells. Am J Physiol (1998) 1.29
UV absorption complicates PCR decontamination. Biotechniques (1992) 1.29
IGF-I and procollagen alpha1(I) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol (2000) 1.24
Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. Am J Physiol (1999) 1.22
Lipopolysaccharide induces recurrence of arthritis in rat joints previously injured by peptidoglycan-polysaccharide. J Exp Med (1987) 1.21
Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain. J Infect Dis (2010) 1.19
Comparison of methods for recovery of Clostridium difficile from an environmental surface. J Clin Microbiol (1983) 1.16
Subtherapeutic corticosteroids potentiate the ability of interleukin 10 to prevent chronic inflammation in rats. Gastroenterology (1998) 1.14
Pharmacology of tamsulosin: saturation-binding isotherms and competition analysis using cloned alpha 1-adrenergic receptor subtypes. Prostate (1997) 1.14
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J Clin Invest (1999) 1.12
Induction of labor with oral prostaglandin E2. Obstet Gynecol (1974) 1.11
Probiotics and inflammatory bowel diseases. Am J Gastroenterol (2000) 1.10
Bacteriotherapy for clostridium difficile colitis. Lancet (1989) 1.07
Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Invest (1992) 1.07
Postoperative recurrence of Crohn's disease: the enemy is within the fecal stream. Gastroenterology (1998) 1.06
alpha 2-Adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha 2-adrenergic receptor subtypes at four distinct levels. Brain Res Mol Brain Res (1995) 1.05
Recurrent pseudobacteremias traced to a radiometric blood culture device. Infect Control (1987) 1.05
Biliary tract disease in rats with experimental small bowel bacterial overgrowth. Hepatology (1991) 1.04
Evidence for peptidoglycan absorption in rats with experimental small bowel bacterial overgrowth. Infect Immun (1991) 1.04
Reactivation of arthritis induced by small bowel bacterial overgrowth in rats: role of cytokines, bacteria, and bacterial polymers. Infect Immun (1995) 1.04
Alpha1-adrenergic receptors in human spinal cord: specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels. Brain Res Mol Brain Res (1999) 1.02
Differential effect of immune cells on non-pathogenic Gram-negative bacteria-induced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunology (2004) 0.98
TNF receptor-associated factor-2 is involved in both IL-1 beta and TNF-alpha signaling cascades leading to NF-kappa B activation and IL-8 expression in human intestinal epithelial cells. J Immunol (1999) 0.97
Insulinlike growth factor I and interleukin 1 beta messenger RNA in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology (1993) 0.97
Inhibitory action of a new sympathomimetic amino (DU-21220) on the nongravid uterus. Am J Obstet Gynecol (1969) 0.96
Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol (2004) 0.96
Fluorescent-antibody test for detection of Clostridium difficile in stool specimens. J Clin Microbiol (1982) 0.96
Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection. Am J Physiol Gastrointest Liver Physiol (2008) 0.96
Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol (2000) 0.96
Cardiac gene delivery with cardiopulmonary bypass. Circulation (2001) 0.95
NF-kappaB signaling proteins as therapeutic targets for inflammatory bowel diseases. Inflamm Bowel Dis (2000) 0.95
Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am J Physiol (1991) 0.94
Local production of corticotropin releasing hormone is increased in experimental intestinal inflammation in rats. Gut (1996) 0.94
Inhibition of premature labor: a multicenter comparison of ritodrine and ethanol. Am J Obstet Gynecol (1977) 0.94
Adenomas induced by polycyclic aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels. Cancer Res (1995) 0.93
Danazol: an antigonadotropic agent in the treatment of pelvic endometriosis. Am J Obstet Gynecol (1975) 0.92
The specificity of peptides bound to human histocompatibility leukocyte antigen (HLA)-B27 influences the prevalence of arthritis in HLA-B27 transgenic rats. J Exp Med (1998) 0.92
Bartonella henselae: etiology of pulmonary nodules in a patient with depressed cell-mediated immunity. Clin Infect Dis (1995) 0.92
Adenoviral gene transfer to the heart during cardiopulmonary bypass: effect of myocardial protection technique on transgene expression. Eur J Cardiothorac Surg (2002) 0.91
The inhibitory effect of diazoxide in normal term labor. Am J Obstet Gynecol (1969) 0.90
Cellular differentiation causes a selective down-regulation of interleukin (IL)-1beta-mediated NF-kappaB activation and IL-8 gene expression in intestinal epithelial cells. J Biol Chem (2000) 0.90
Assignment of the agent of Tyzzer's disease to Clostridium piliforme comb. nov. on the basis of 16S rRNA sequence analysis. Int J Syst Bacteriol (1993) 0.89
Identification and characterization of rat intestinal lamina propria cells: consequences of microbial colonization. Vet Immunol Immunopathol (1992) 0.89
The effect of danazol in the treatment of chronic cystic mastitis. Obstet Gynecol (1976) 0.88